GNA is developing new technologies for molecular diagnostics, including a rapid diagnostic system for Covid-19. The GNA Neo system can diagnose up to eight samples simultaneously in a short time and can be used close to the customer. GNA technology has also been used with more than 30 assays for research purposes, including MRSA, tuberculosis, Ebola and plague.
